Advertisement
Demo

Breckenridge obtains FDA nod for generic Jevtana

Aug 06, 2022 , Drug Store News - Retail
Jevtana is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen.

Read the full story...


Trending healthcare news keywords at this moment

covid- care healthcare risk covid death study suggests children shows major pay medical drug million fda mental launches st court walmart people early loss benefits company monkeypox